Opana FDA Approval History
FDA Approved: Yes (Discontinued) (First approved June 22, 2006)
Brand name: Opana
Generic name: oxymorphone
Dosage form: Tablets and ER Tablets
Company: Endo Pharmaceuticals Inc.
Treatment for: Pain
Marketing Status: Discontinued
Opana (immediate-release) and Opana ER (extended-release) are oral formulations of the opioid analgesic oxymorphone, used for the relief of moderate-to-severe pain. Opana is indicated for the relief of acute pain where the use of an opioid is appropriate, and Opana ER is indicated for patients requiring continuous, around-the-clock opioid treatment for an extended period of time.
Development Timeline for Opana
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.